PROGEN CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,980 KRW | 0.00% |
|
-6.71% | -16.36% |
| 1 week | -6.71% | ||
| Current month | -11.14% | ||
| 1 month | -14.08% | ||
| 3 months | -25.44% | ||
| Current year | -16.36% |
1 week
5 550.00
6 400.00
1 month
5 550.007 000.00
Current year
5 550.009 380.00
1 year
2 465.009 380.00
3 years
2 465.009 380.00
5 years
2 465.009 380.00
10 years
2 465.009 380.00
Progen Co Ltd is a Korea-based company principally engaged in the researching and developing new drugs. The Company produces metabolic disease treatment drugs, immune disease treatment drugs, immune anticancer drugs, and others. The Company was established in 1998.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.36% | 50.19M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- A296160 Stock
